Francis Lawrence explains that his and Viola Davis' initial approach to Volumnia Gaul's personality was inspired by Gene Wilder's Willy Wonka.
The Big Picture Even though the elite who live at the Capitol would love to get their hands on a Wonka chocolate bar, a crossover between The Hunger Games: The Ballad of Songbirds and Snakes and Charlie and the Chocolate Factory is unlikely. However, director Francis Lawrence told Collider that the 1971 children's movie kept coming back to him when thinking of one character in particular: Dr. Volumnia Gaul.
"You know, weirdly, we had a long Zoom, and we chatted about the themes of the book and how her character connects to the themes. My reference, and I was a little nervous to say this to her, but my reference for Gaul was actually Gene Wilder's Willy Wonka.
In fact, Gene Wilder’s creepiness as Willy Wonka became such a trademark for the character that long-time fans of the film missed it when the story was remade by Tim Burton and Johnny Depp. Now, we’ll have to see if Timothée Chalamet brings any of that to the character's origin story, but before that, we can find out how Davis took inspiration from Wilder when the Hunger Games prequel hits the big screen in just a few weeks.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The Hunger Games: The Ballad of Songbirds and Snakes Lands SAG-AFTRA Interim AgreementRachel Zegler, Viola Davis, and more can now promote the upcoming prequel.
Read more »
FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up studyA panel of advisers to the U.S. health regulator said on Tuesday Vertex Pharmaceuticals (VRTX.O) and CRISPR Therapeutics (CRSP.BN) could assess potential safety risks of their sickle cell disease gene therapy after approval.
Read more »
FDA advisers see no roadblocks for gene-editing treatment for sickle cell diseaseAdvisers to the Food and Drug Administration meeting Tuesday paved the way for the first treatment of human disease using the gene-editing technique CRISPR. The agency has a December deadline.
Read more »
FDA moves closer to sickle cell cure that uses gene editingBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »
Murky road ahead for Duchenne gene therapy as confirmatory trial misses main goalWhen the first gene therapy for the rare, debilitating disease Duchenne muscular dystrophy was conditionally approved earlier this year, it was hailed as a seminal moment for patients and their families — an opportunity to try to slow the progression of a disease that robs kids of their ability to walk by their teen years, and can be fatal by age...
Read more »
FDA Advisors Consider Crispr Gene-Editing Treatment for Sickle Cell AnemiaNearly all patients treated so far have been relieved of the blood-clogging crises of the disease.
Read more »